Doctor profile · Federal record

Dr. Teresa Grossi, N.P.

Nurse Practitioner · Valencia, CA

  • NPI 1700935103
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 22 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
28212 Kelly Johnson Pkwy, Suite 245
Valencia, CA 913555084
(661) 254-3686
fax (661) 254-5671
Additional location
1700 N Rose Ave Ste 450
Oxnard, CA 930307628
(805) 201-7150
fax (805) 278-0137
Additional location
2438 N Ponderosa Dr Ste C105
Camarillo, CA 930102465
(805) 388-2068
fax (805) 484-7700

Credentials & registration

NPPES · NUCC
NPI registered
January 2007 — 19 yrs on file
Profile last updated
November 6, 2020
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
California #NP15948

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1700935103. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,939
Distinct HCPCS
10
Medicare allowed
$96,895
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 793 117 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 388 258 $83
17000 Destruction of precancer skin growth, 1 growth 197 146 $51
17110 Destruction of skin growth, 1-14 growths 177 136 $109
99203 New patient office or other outpatient visit, 30-44 minutes 87 87 $101
99212 Established patient office or other outpatient visit, 10-19 minutes 73 57 $52
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 56 13 $1
11102 Biopsy of related skin growth, first growth 49 44 $87
17004 Destruction of precancer skin growth, 15 or more growths 40 29 $161
11103 Biopsy of related skin growth, each additional growth 24 16 $48

In context: peer comparison

Among 2 peers in Valencia Nurse Practitioner, average services per provider: 121. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$997
Transactions
39
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 9 $178.12
Genzyme Corporation 4 $121.86
Regeneron Healthcare Solutions, INC. 4 $115.36
Ucb, INC. 3 $94.60
Lilly USA, LLC 3 $71.23
Galderma Laboratories, L.P. 3 $64.32
Sun Pharmaceutical Industries INC. 2 $60.72
Abbvie INC. 2 $60.68
Strata Skin Sciences, INC. 1 $58.29
Dermavant Sciences, INC. 2 $48.07
Verrica Pharmaceuticals INC. 2 $42.87
Amgen INC. 2 $30.99
Incyte Corporation 1 $27.37
Novartis Pharmaceuticals Corporation 1 $22.02

By nature of payment

Food and Beverage
$997

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
467
Patients
264
Total drug cost
$18,620
Drug Type Claims Patients Total cost
Mometasone Furoate Generic 107 81 $2,130
Clobetasol Propionate Generic 53 30 $5,404
Fluocinonide Generic 52 29 $1,914
Ketoconazole Generic 40 14 $961
Mupirocin Generic 38 31 $340
Triamcinolone Acetonide Generic 38 22 $621
Clindamycin Phosphate Generic 24 0 $744
Tretinoin Generic 23 13 $1,744
Econazole Nitrate Generic 20 15 $703
Metronidazole Generic 19 15 $1,104

Frequently asked questions

Auto-generated from federal data
What is Dr. Teresa Grossi's medical specialty?
Dr. Teresa Grossi practices Nurse Practitioner in Valencia, CA.
Where does Dr. Teresa Grossi practice?
Dr. Teresa Grossi practices at 28212 Kelly Johnson Pkwy, Valencia, CA 913555084. Office phone: 6612543686.
What is Dr. Teresa Grossi's NPI?
Dr. Teresa Grossi's National Provider Identifier (NPI) is 1700935103, issued by NPPES.
Does Dr. Teresa Grossi accept Medicare assignment?
Yes. Dr. Teresa Grossi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Teresa Grossi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.